Company Filing History:
1 out of 163 
1 out of 1,455 
Years Active: 2024
Title: Evelyne Dombrecht: Innovator in Cancer Treatment
Introduction
Evelyne Dombrecht is a notable inventor based in Zwijnaarde, Belgium. She has made significant contributions to the field of cancer treatment through her innovative research and development of novel therapeutic agents.
Latest Patents
Dombrecht holds a patent for her work titled "Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and T cell receptor." This technology aims to provide a new type of drug for treating subjects suffering from cancer. The invention includes polypeptides that comprise at least four immunoglobulin single variable domains (ISVDs), with one ISVD binding to TCR and at least two ISVDs binding to GPC3. Additionally, the technology encompasses nucleic acids, vectors, and compositions.
Career Highlights
Throughout her career, Evelyne Dombrecht has worked with prominent companies in the pharmaceutical industry, including Ablynx N.V. and Sanofi. Her experience in these organizations has allowed her to advance her research and contribute to the development of innovative cancer therapies.
Collaborations
Dombrecht has collaborated with esteemed colleagues such as Daniel Janssen and Carlo Boutton. These partnerships have played a crucial role in enhancing her research and expanding the impact of her inventions.
Conclusion
Evelyne Dombrecht is a pioneering inventor whose work in cancer treatment exemplifies the potential of innovative therapies. Her contributions to the field are significant and continue to inspire advancements in medical science.